BioSpace News Archive

A recent study by the Nationwide Retirement Institute revealed that three in four older adults would prefer to receive long-term care in their own homes.

Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage pharmaceutical company, announced today the Company completed dosing in the third and final cohort in the Phase 1 trial investigating the use of delayed release tablets for colonic delivery of Brilacidin in healthy volunteers.

The Healthcare Information and Management Systems Society and Elsevier, the global information analytics business specializing in science and health, are proud to announce the call for submissions for the Annual HIMSS-Elsevier Digital Healthcare Award 2020, European edition.

Generex Biotechnology Corporation (OTCQB:GNBT) today announced that Richard Purcell, the company’s Executive Vice President of Research & Development conducted an interview with Mike Elliott of CEO Roadshow, which is available at:

Abbott (NYSE: ABT) today announced it received approval from the U.S. Food and Drug Administration (FDA) for a new, expanded indication for the company’s Infinity™ Deep Brain Stimulation (DBS) system to include targeting of an area of the brain called the internal globus pallidus (GPi).

ATAI Life Sciences AG (“ATAI” or the “Company”), a global biotech platform that envisions an end to mental illnesses, today announced an investment in two separate joint ventures (JV) with DemeRx, a clinical stage pharmaceutical company focused on developing ibogaine and noribogaine for the treatment of opioid use disorder (OUD).

Bureau Veritas a world-leader in testing, inspection, and certification (TIC) services, today announced that Ron Stupi has been appointed to senior vice president and chief operating officer of its building and infrastructure (B&I) team, part of its Commodities, Infrastructure, and Facilities (CIF) division in North America, effective immediately.

To date, there have been 830 confirmed cases and 26 deaths - all but two of the fatalities have been in Wuhan and most have been elderly

AI platform was developed at the Ray and Stephanie Lane Center for Computational Biology, which became the Computational Biology Department at Carnegie Mellon University and was successfully tested by several pharma companies

Oncopeptides AB (Nasdaq Stockholm: ONCO) announces today that it will host a webcast at 11am (CET) on Monday, January 27th 2020 where CEO Jakob Lindberg will present and explain melflufen’s mechanism of action.